InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Durgam Suresh K., Directeur Médical. Officer active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 19 disclosures have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €2.1m. Activity tracked since 18 January 2022. The latest transaction was filed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Durgam Suresh K.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
42,913 shares@ US$132.0060.4% of flowCommon StockSEC:0000950170-25-049593:0
13,133 sharesCommon StockSEC:0000950170-25-036594:0
8,742 sharesCommon StockSEC:0000950170-25-032584:0
11,017 shares0Common StockSEC:0000950170-25-013749:0
3,728 shares@ US$66.342.6% of flowCommon StockSEC:0000950170-24-029578:0
13,132 sharesCommon StockSEC:0000950170-24-028818:0
7,907 sharesCommon StockSEC:0000950170-24-021565:0
11,860 shares0Common StockSEC:0000950170-24-011389:0
62,282 shares@ US$19.8713.0% of flowCommon StockSEC:0000950170-24-002240:0
21,262 shares@ US$65.0014.9% of flowCommon StockSEC:0000950170-23-070815:0
1,842 shares@ US$65.001.2% of flowCommon StockSEC:0001209191-23-042937:0
7,344 sharesCommon StockSEC:0001209191-23-018287:0
7,906 sharesCommon StockSEC:0001209191-23-013438:0
8,354 sharesCommon StockSEC:0001209191-23-011999:0
4,177 shares@ US$56.982.6% of flowCommon StockSEC:0001209191-22-016447:0
7,906 sharesCommon StockSEC:0001209191-22-013363:0
8,354 sharesCommon StockSEC:0001209191-22-012396:0
6,223 shares@ US$42.032.7% of flowCommon StockSEC:0001209191-22-004015:0
13,093 sharesCommon StockSEC:0001209191-22-002993:0
19 of 19 declarations
About Durgam Suresh K.
Durgam Suresh K. is Directeur Médical and EVP, Chief Medical Officer at Intra-Cellular Therapies, Inc. The declarant has 19 filings in total, and across the 19 recent filings tracked from 2022-01-11 to 2025-04-02, sales amount to EUR 7,248,933 and the most frequent transaction nature is Levée d'options.
